Riam Shammaa

Director/Board Member at DEFENCE THERAPEUTICS INC.

Health Technology

Profile

Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.

Riam Shammaa active positions

Companies	Position	Start
DEFENCE THERAPEUTICS INC.	Director/Board Member	09/11/2021
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Chief Executive Officer	04/02/2019

All active positions of Riam Shammaa

Former positions of Riam Shammaa

Companies	Position	End
Pallianera Pharma, Inc.	Founder	-

See the detail of Riam Shammaa's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Riam Shammaa's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
DEFENCE THERAPEUTICS INC.	Health Technology

Private companies	2
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Health Technology
Pallianera Pharma, Inc.